This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Accelrys Announces The Scientific Innovation Lifecycle Leaders Awards

SAN DIEGO, April 4, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced a new award honoring companies that are closing the productivity gap from innovation through commercialization – the Scientific Innovation Lifecycle Leaders Awards.


The awards recognize companies that leverage pioneering technology solutions and processes to accelerate new product innovation, speed time-to-market and increase profitability. According to Accelrys President and Chief Executive Officer Max Carnecchia, "Every day, companies that rely on science are undertaking new technology initiatives designed to increase their efficiency and competitiveness, and bring products to market faster. The trailblazers of the industry are pushing the boundaries and creating entirely new approaches that don't rely on traditional paradigms – they are forging new paths that will impact their industries for years to come.  Accelrys is proud to honor these industry leaders and the changes they are making to close the productivity gap and revolutionize R&D."

Accelrys will annually confer the awards in four categories – Life Sciences Research and Development; Materials Science and Engineering; Process Management and Compliance; and Excellence in Enterprise Informatics Implementation. Customers of Accelrys that exemplify best practices in managing their Scientific Innovation Lifecycle are invited to submit. Applications should outline:
  • Why this project makes the organization a scientific innovation lifecycle leader? How did it improve R&D and product development within the organization?
  • How this project pushed the boundaries, moving beyond traditional approaches?  
  • The specific project or organizational changes the company undertook and the functional area(s) it impacted – research, development, QA/QC or manufacturing.
  • Challenges and obstacles faced in the undertaking the project or changes.
  • Key team members.
  • How the project succeeded – from new scientific approaches and driving innovation to streamlining internal processes to quantitative results – and any expected future outcomes.   

Submission Details
  • Submissions are being accepted until April 30, 2013.
  • Submissions can be created in the format of the nominator's choice (videos should be under five minutes and written submissions less than 1,000 words)
  • Submissions should be sent to Accelrys.
  • Accelrys retains the right to publish portions of or full submissions unless confidentiality is requested by the nominator.

About Accelrys, Inc.Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, California, USA, Accelrys employs more than 200 full-time Ph.D scientists. For more information about Accelrys, visit

Related Links Accelrys Website Follow Accelrys on Twitter Friend Accelrys on Facebook Accelrys' YouTube Channel Connect with Accelrys on LinkedIn

SOURCE Accelrys, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community


Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs